DexCom, Inc. (DXCM) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Dexcom, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.676 and investor relations. Mr. Christensen, you may begin. 00:00:05.900 -- 00:00:10.587 Thank you, operator, and welcome to Dexcom's second quarter 2025 earnings call. 00:00:10.587 -- 00:00:14.933 Our agenda begins with Kevin Sayre, Dexcom's chairman and CEO, who will summarize our 00:00:14.933 -- 00:00:18.939 recent highlights and ongoing strategic initiatives, followed by a financial review and 00:00:18.939 -- 00:00:22.504 outlook from Jeremy Sylvain, our chief financial officer. 00:00:22.504 -- 00:00:25.563 Following our prepared remarks, we will open the call up for your questions. 00:00:25.563 -- 00:00:29.148 At that time, we ask analysts to limit themselves to one question each so we can provide 00:00:29.148 -- 00:00:31.832 an opportunity for everyone participating today. 00:00:31.832 -- 00:00:36.078 Please note that there are also slides available related to our second quarter 2025 performance 00:00:36.078 -- 00:00:40.445 on the Dexcom Investor Relations website on the events and presentations page. 00:00:40.445 -- 00:00:43.109 With that, let's review our safe harbor statement. 00:00:43.109 -- 00:00:47.094 Some of the statements we will make on today's call may constitute forward-looking statements. 00:00:47.094 -- 00:00:51.281 These statements reflect management's intentions, beliefs, and expectations about future 00:00:51.281 -- 00:00:56.136 events, strategies, competition, products, operating plans, and performance. 00:00:56.136 -- 00:01:00.342 All forward-looking statements included on this call are made as of the date hereof based 00:01:00.342 -- 00:01:05.208 on information currently available to Dexcom, are subject to various risks and uncertainties, 00:01:05.208 -- 00:01:09.093 and actual results could differ materially ...